FORMULARY DECISION
Tofacitinib : Xeljanz
SMC2116 : In combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior diseas...
We have found 12 results when searching "Tofacitinib"
SMC2116 : In combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior diseas...
SMC2122 : For the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to conventional therapy or a ...